Gilead Sciences (GILD) FY2023 results: revenue $27.1 billion, down 0.6% on the year
Gilead Sciences, Inc. (GILD) reported revenue of $27.1 billion for fiscal 2023, the year ended 31 December 2023, down 0.6% on the year before. Net income was $5.7 billion, up 23.4%, and diluted earnings per share $4.50. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2024.
Revenue
$27.1 billion
-0.6% on the year
FY2016FY2023
Operating margin
28.0%
26.9% a year earlier
FY2016FY2023
Net income
$5.7 billion
+23.4% on the year
FY2016FY2023
Diluted EPS
$4.50
+23.6% on the year
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
8,006
9,072
11,384
-11.8%
Capital expenditure
585
728
579
-19.6%
Free cash flow
7,421
8,344
10,805
-11.1%
Free cash flow margin
27.4%
30.6%
39.6%
Cash from investing
-2,265
-2,466
-3,131
Cash from financing
-5,125
-6,469
-8,877
Depreciation and amortisation
2,654
2,123
2,029
+25.0%
Share-based compensation
766
637
635
+20.3%
Buybacks
1,000
1,396
546
-28.4%
Dividends paid
3,809
3,709
3,605
+2.7%
Dividend per share
$3.00
$2.92
$2.84
+2.7%
Diluted shares, weighted
1,258m
1,262m
1,262m
-0.3%
Shares outstanding at period end
1,246m
1,247m
1,254m
-0.1%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
22,833
21,240
21,069
+7.5%
Non-controlling interest
-84.0
-31.0
-5.0
Debt
24,987
25,229
26,695
-1.0%
Operating lease liabilities
546
467
489
+16.9%
Other liabilities
13,843
16,266
19,704
-14.9%
Total liabilities and equity
62,125
63,171
67,952
-1.7%
Fixed assets
5,317
5,475
5,121
-2.9%
Goodwill
8,314
8,314
8,332
0.0%
Intangible assets
26,454
28,894
33,455
-8.4%
Investments
2,342
2,218
2,491
+5.6%
Cash and equivalents
6,085
5,412
5,338
+12.4%
Receivables
4,660
4,777
4,493
-2.4%
Inventory
1,787
1,507
1,618
+18.6%
Other assets
7,166
6,574
7,104
+9.0%
Total assets
62,125
63,171
67,952
-1.7%
10-K for the year ended 31 December 2023, filed 23 February 2024: the filing.